CyberKnife® for Lung Tumors

CyberKnife robotic radiosurgery painlessly delivers precise beams of radiation to tumors and lesions, without requiring incisions, hospitalization, or long recovery time. It can serve as an effective lung cancer treatment and is an especially good option for patients with early stage lung cancer, complex tumors or patients who prefer a non-invasive way to treat their cancer. CyberKnife has the ability to track tumors in real time. That means patients breathe normally during each treatment session, since the radiation beam adjusts automatically to the tumor location.

CYBERKNIFE WITH INTENT TO CURE FOR STAGE I-II LUNG CANCER

Pre-Treatment

pre

4 Years Post-Treatment

post

A retrospective look at Stage I and II lung cancer patients treated at St. Louis CyberKnife has offered invaluable information and yielded excellent outcomes which are comparable to current published data. Dr. John Bedwinek, radiation oncologist with SSM Health Cancer Care and St. Louis CyberKnife, led the efforts to collect data from 2007 through 2015 on non-small cell lung cancer patients treated with CyberKnife with intent to cure. 150 patients were identified and 191 tumors were treated (multiple primaries). We looked at local control, survival, and complications.

Key Advantages of CyberKnife for Lung Tumors

  • Treats patients in 5 or fewer visits, depending on tumor size, volume, and location
  • Constantly corrects for patient/tumor movement throughout treatment, ensuring radiation beams are always locked on tumor during treatment
  • Respiratory tracking feature requires no breath-holding or respiratory gating by patient
  • Reaches tumors from virtually unlimited directions with robotic mobility
  • Enables clinicians to maximize and conform the dose to the tumor target while limiting radiation exposure to surrounding healthy tissue
  • Outpatient procedure, little or no recovery time and minimal side effects
  • Requires no anesthesia
  • Allows for an immediate return to normal activities

National Comprehensive Cancer Network Guidelines

Speak with one of our Team Members about how we can help.